Cosmo Pharmaceuticals Investor Relations Material
Latest events
H2 2024
Cosmo Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cosmo Pharmaceuticals N.V.
Access all reports
Established in 1997, Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. The company offers drug delivery systems primarily rectal, topical, oral, nasal wafer based systems. Cosmo Pharmaceuticals aims to become a global leader in optimized therapies for selected gastroenterology and colorectal disease areas by leveraging its proprietary and differentiated technology.
Key slides for Cosmo Pharmaceuticals N.V.
H1 2024
Cosmo Pharmaceuticals N.V.
H2 2024
Cosmo Pharmaceuticals N.V.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
COPN
Country
🇨🇭 Switzerland